Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in Diffuse Large B-cell Lymphoma transformation.

Carreras J, Lopez-Guillermo A, Kikuti YY, Itoh J, Masashi M, Ikoma H, Tomita S, Hiraiwa S, Hamoudi R, Rosenwald A, Leich E, Martinez A, Roncador G, Villamor N, Colomo L, Perez P, Tsuji NM, Campo E, Nakamura N.

J Clin Exp Hematop. 2019;59(1):1-16. doi: 10.3960/jslrt.19003.

2.

Primary cutaneous vs secondary cutaneous follicular lymphomas: A comparative study focused on BCL2, CD10, and t(14;18) expression.

Servitje O, Climent F, Colomo L, Ruiz N, García-Herrera A, Gallardo F, Mercadal S, Pomares H, Muniesa C, Martin-Callizo C, Marcoval J, Rovira R, Estrach T, Pujol RM.

J Cutan Pathol. 2019 Mar;46(3):182-189. doi: 10.1111/cup.13399. Epub 2018 Dec 26.

PMID:
30511443
3.

Fast extraction of cannabinoids in marijuana samples by using hard-cap espresso machines.

Leiman K, Colomo L, Armenta S, de la Guardia M, Esteve-Turrillas FA.

Talanta. 2018 Dec 1;190:321-326. doi: 10.1016/j.talanta.2018.08.009. Epub 2018 Aug 6.

PMID:
30172516
4.

Pharmacological modulation of CXCR4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphoma.

Recasens-Zorzo C, Cardesa-Salzmann T, Petazzi P, Ros-Blanco L, Esteve-Arenys A, Clot G, Guerrero-Hernández M, Rodríguez V, Soldini D, Valera A, Moros A, Climent F, González-Barca E, Mercadal S, Arenillas L, Calvo X, Mate JL, Gutiérrez-García G, Casanova I, Mangues R, Sanjuan-Pla A, Bueno C, Menéndez P, Martínez A, Colomer D, Tejedor RE, Teixidó J, Campo E, López-Guillermo A, Borrell JI, Colomo L, Pérez-Galán P, Roué G.

Haematologica. 2019 Apr;104(4):778-788. doi: 10.3324/haematol.2017.180505. Epub 2018 Jun 28.

5.

Essential thrombocythaemia with mutation in MPL: clinicopathological correlation and comparison with JAK2V617F-mutated and CALR-mutated genotypes.

Alvarez-Larran A, Martínez D, Arenillas L, Rubio A, Arellano-Rodrigo E, Hernández Boluda JC, Papaleo N, Caballero G, Martínez C, Ferrer-Marín F, Mata MI, Pérez-Encinas M, Durán MA, Alonso JM, Carreño-Tarragona G, Alonso JM, Noya S, Magro E, Pérez R, López-Guerra M, Pastor-Galán I, Cervantes F, Besses C, Colomo L, Rozman M.

J Clin Pathol. 2018 Nov;71(11):975-980. doi: 10.1136/jclinpath-2018-205227. Epub 2018 Jun 22.

PMID:
29934356
6.

Novel phosphorylated TAK1 species with functional impact on NF-κB and β-catenin signaling in human Cutaneous T-cell lymphoma.

Gallardo F, Bertran J, López-Arribillaga E, González J, Menéndez S, Sánchez I, Colomo L, Iglesias M, Garrido M, Santamaría-Babí LF, Torres F, Pujol RM, Bigas A, Espinosa L.

Leukemia. 2018 Oct;32(10):2211-2223. doi: 10.1038/s41375-018-0066-4. Epub 2018 Feb 22.

7.

Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets.

Karube K, Enjuanes A, Dlouhy I, Jares P, Martin-Garcia D, Nadeu F, Ordóñez GR, Rovira J, Clot G, Royo C, Navarro A, Gonzalez-Farre B, Vaghefi A, Castellano G, Rubio-Perez C, Tamborero D, Briones J, Salar A, Sancho JM, Mercadal S, Gonzalez-Barca E, Escoda L, Miyoshi H, Ohshima K, Miyawaki K, Kato K, Akashi K, Mozos A, Colomo L, Alcoceba M, Valera A, Carrió A, Costa D, Lopez-Bigas N, Schmitz R, Staudt LM, Salaverria I, López-Guillermo A, Campo E.

Leukemia. 2018 Mar;32(3):675-684. doi: 10.1038/leu.2017.251. Epub 2017 Aug 14.

8.

LMO2-negative Expression Predicts the Presence of MYC Translocations in Aggressive B-Cell Lymphomas.

Colomo L, Vazquez I, Papaleo N, Espinet B, Ferrer A, Franco C, Comerma L, Hernandez S, Calvo X, Salar A, Climent F, Mate JL, Forcada P, Mozos A, Nonell L, Martinez A, Carrio A, Costa D, Dlouhy I, Salaverria I, Martin-Subero JI, Lopez-Guillermo A, Valera A, Campo E; Grup per l’Estudi dels Limfomes de Catalunya i Balears (GELCAB).

Am J Surg Pathol. 2017 Jul;41(7):877-886. doi: 10.1097/PAS.0000000000000839. Erratum in: Am J Surg Pathol. 2019 Mar;43(3):434.

PMID:
28288039
9.

HHV8-related lymphoid proliferations: a broad spectrum of lesions from reactive lymphoid hyperplasia to overt lymphoma.

Gonzalez-Farre B, Martinez D, Lopez-Guerra M, Xipell M, Monclus E, Rovira J, Garcia F, Lopez-Guillermo A, Colomo L, Campo E, Martinez A.

Mod Pathol. 2017 May;30(5):745-760. doi: 10.1038/modpathol.2016.233. Epub 2017 Jan 13.

10.

MicroRNAs 142-3p, miR-155 and miR-203 Are Deregulated in Gastric MALT Lymphomas Compared to Chronic Gastritis.

Fernández C, Bellosillo B, Ferraro M, Seoane A, Sánchez-González B, Pairet S, Pons A, Barranco L, Vela MC, Gimeno E, Colomo L, Besses C, Navarro A, Salar A.

Cancer Genomics Proteomics. 2017 Jan 2;14(1):75-82.

11.

Blastic Plasmacytoid Dendritic Cell Neoplasm Associated with Dystrophic Xanthomatosis after Chemotherapy.

García-Colmenero L, Gallardo F, Salar A, Alvarez-Larrán A, Colomo L, Pujol RM.

Acta Derm Venereol. 2017 Feb 8;97(2):293-294. doi: 10.2340/00015555-2515. No abstract available.

12.

Definition of MYC genetic heteroclonality in diffuse large B-cell lymphoma with 8q24 rearrangement and its impact on protein expression.

Valera A, Epistolio S, Colomo L, Riva A, Balagué O, Dlouhy I, Tzankov A, Bühler M, Haralambieva E, Campo E, Soldini D, Mazzucchelli L, Martin V.

Mod Pathol. 2016 Aug;29(8):844-53. doi: 10.1038/modpathol.2016.71. Epub 2016 Apr 29.

13.

MYD88 L265P Mutations, But No Other Variants, Identify a Subpopulation of DLBCL Patients of Activated B-cell Origin, Extranodal Involvement, and Poor Outcome.

Rovira J, Karube K, Valera A, Colomer D, Enjuanes A, Colomo L, Martínez-Trillos A, Giné E, Dlouhy I, Magnano L, Delgado J, Martínez A, Villamor N, Campo E, López-Guillermo A.

Clin Cancer Res. 2016 Jun 1;22(11):2755-64. doi: 10.1158/1078-0432.CCR-15-1525. Epub 2016 Jan 20.

14.

Partial lack of BCL2 in follicular lymphoma: An unusual immunohistochemical staining pattern explained by ongoing BCL2 mutation.

van den Brand M, Garcia-Garcia M, Mathijssen JJ, Colomo L, Groenen PJ, Serrano S, van Krieken JH.

Pathol Res Pract. 2016 Feb;212(2):148-50. doi: 10.1016/j.prp.2015.12.001. Epub 2015 Dec 9.

PMID:
26725534
15.

Prognosis of patients with diffuse large B cell lymphoma not reaching complete response or relapsing after frontline chemotherapy or immunochemotherapy.

Rovira J, Valera A, Colomo L, Setoain X, Rodríguez S, Martínez-Trillos A, Giné E, Dlouhy I, Magnano L, Gaya A, Martínez D, Martínez A, Campo E, López-Guillermo A.

Ann Hematol. 2015 May;94(5):803-12. doi: 10.1007/s00277-014-2271-1. Epub 2014 Dec 14.

16.

CD8-positive peripheral T-cell lymphoma with aberrant expression of CD20 and concurrent in situ follicular lymphoma.

Sagasta A, Molina-Urra R, Martinez D, Gonzalez-Farre B, Marti E, Herranz MJ, Estrach T, Campo E, Colomo L.

J Cutan Pathol. 2015 Jan;42(1):66-72. doi: 10.1111/cup.12409. Epub 2014 Dec 8.

PMID:
25354337
17.

Evaluation of unexplained peripheral lymphadenopathy and suspected malignancy using a distinct quick diagnostic delivery model: prospective study of 372 patients.

Bosch X, Coloma E, Donate C, Colomo L, Doti P, Jordán A, López-Soto A.

Medicine (Baltimore). 2014 Oct;93(16):e95. doi: 10.1097/MD.0000000000000095.

18.

In vivo intratumoral Epstein-Barr virus replication is associated with XBP1 activation and early-onset post-transplant lymphoproliferative disorders with prognostic implications.

Gonzalez-Farre B, Rovira J, Martinez D, Valera A, Garcia-Herrera A, Marcos MA, Sole C, Roue G, Colomer D, Gonzalvo E, Ribera-Cortada I, Araya M, Lloreta J, Colomo L, Campo E, Lopez-Guillermo A, Martinez A.

Mod Pathol. 2014 Dec;27(12):1599-611. doi: 10.1038/modpathol.2014.68. Epub 2014 Apr 25.

19.

A case of lung involvement due to anaplastic lymphoma kinase negative anaplastic large cell lymphoma in an HIV-infected patient.

Constanza Lucero M, Fernandez S, Castro P, Colomo L, Moreno PJ, Moreno A, Nicolas JM.

AIDS. 2014 Mar 27;28(6):934-6. doi: 10.1097/QAD.0000000000000185. No abstract available.

PMID:
24614068
20.

Analysis of the IGHV region in Burkitt's lymphomas supports a germinal center origin and a role for superantigens in lymphomagenesis.

Baptista MJ, Calpe E, Fernandez E, Colomo L, Cardesa-Salzmann TM, Abrisqueta P, Bosch F, Crespo M.

Leuk Res. 2014 Apr;38(4):509-15. doi: 10.1016/j.leukres.2014.01.001. Epub 2014 Jan 13.

PMID:
24480549
21.

Assessment of SOX11 expression in routine lymphoma tissue sections: characterization of new monoclonal antibodies for diagnosis of mantle cell lymphoma.

Soldini D, Valera A, Solé C, Palomero J, Amador V, Martin-Subero JI, Ribera-Cortada I, Royo C, Salaverria I, Beà S, Gonzalvo E, Johannesson H, Herrera M, Colomo L, Martinez A, Campo E.

Am J Surg Pathol. 2014 Jan;38(1):86-93. doi: 10.1097/PAS.0b013e3182a43996.

22.

Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.

Beà S, Valdés-Mas R, Navarro A, Salaverria I, Martín-Garcia D, Jares P, Giné E, Pinyol M, Royo C, Nadeu F, Conde L, Juan M, Clot G, Vizán P, Di Croce L, Puente DA, López-Guerra M, Moros A, Roue G, Aymerich M, Villamor N, Colomo L, Martínez A, Valera A, Martín-Subero JI, Amador V, Hernández L, Rozman M, Enjuanes A, Forcada P, Muntañola A, Hartmann EM, Calasanz MJ, Rosenwald A, Ott G, Hernández-Rivas JM, Klapper W, Siebert R, Wiestner A, Wilson WH, Colomer D, López-Guillermo A, López-Otín C, Puente XS, Campo E.

Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18250-5. doi: 10.1073/pnas.1314608110. Epub 2013 Oct 21.

23.

MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.

Valera A, López-Guillermo A, Cardesa-Salzmann T, Climent F, González-Barca E, Mercadal S, Espinosa I, Novelli S, Briones J, Mate JL, Salamero O, Sancho JM, Arenillas L, Serrano S, Erill N, Martínez D, Castillo P, Rovira J, Martínez A, Campo E, Colomo L; Grup per l’Estudi dels Limfomes de Catalunya i Balears (GELCAB).

Haematologica. 2013 Oct;98(10):1554-62. doi: 10.3324/haematol.2013.086173. Epub 2013 May 28.

24.

ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements.

Valera A, Colomo L, Martínez A, de Jong D, Balagué O, Matheu G, Martínez M, Taddesse-Heath L, Jaffe ES, Bacchi CE, Campo E.

Mod Pathol. 2013 Oct;26(10):1329-37. doi: 10.1038/modpathol.2013.73. Epub 2013 Apr 19.

25.

Plasmablastic transformation of low-grade B-cell lymphomas: report on 6 cases.

Martinez D, Valera A, Perez NS, Sua Villegas LF, Gonzalez-Farre B, Sole C, Gine E, Lopez-Guillermo A, Roue G, Martinez S, Sant F, Warzocha K, Robak T, Czader M, Villamor N, Colomo L, Campo E, Martinez A.

Am J Surg Pathol. 2013 Feb;37(2):272-81. doi: 10.1097/PAS.0b013e31826cb1d1.

PMID:
23282972
26.

A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma.

Perry AM, Cardesa-Salzmann TM, Meyer PN, Colomo L, Smith LM, Fu K, Greiner TC, Delabie J, Gascoyne RD, Rimsza L, Jaffe ES, Ott G, Rosenwald A, Braziel RM, Tubbs R, Cook JR, Staudt LM, Connors JM, Sehn LH, Vose JM, López-Guillermo A, Campo E, Chan WC, Weisenburger DD.

Blood. 2012 Sep 13;120(11):2290-6. doi: 10.1182/blood-2012-05-430389. Epub 2012 Jun 26.

27.

Numb chin syndrome with vagal and hypoglossal paralysis: an initial sign of an uncommon diagnosis.

García-Álvarez SM, Olondo-Zulueta L, Pericás JM, Colomo L, Bosch X.

Am J Med Sci. 2012 Sep;344(3):241-4. doi: 10.1097/MAJ.0b013e318256050f.

PMID:
22739563
28.

SOX11 is useful in differentiating cyclin D1-positive diffuse large B-cell lymphoma from mantle cell lymphoma.

Hsiao SC, Cortada IR, Colomo L, Ye H, Liu H, Kuo SY, Lin SH, Chang ST, Kuo TU, Campo E, Chuang SS.

Histopathology. 2012 Oct;61(4):685-93. doi: 10.1111/j.1365-2559.2012.04260.x.

PMID:
22642745
29.

Nonhepatosplenic γδ T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation.

Garcia-Herrera A, Song JY, Chuang SS, Villamor N, Colomo L, Pittaluga S, Alvaro T, Rozman M, de Anda Gonzalez J, Arrunategui AM, Fernandez E, Gonzalvo E, Estrach T, Colomer D, Raffeld M, Gaulard P, Campo E, Jaffe ES, Martinez A.

Am J Surg Pathol. 2011 Aug;35(8):1214-25. doi: 10.1097/PAS.0b013e31822067d1.

30.

High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy.

Cardesa-Salzmann TM, Colomo L, Gutierrez G, Chan WC, Weisenburger D, Climent F, González-Barca E, Mercadal S, Arenillas L, Serrano S, Tubbs R, Delabie J, Gascoyne RD, Connors JM, Mate JL, Rimsza L, Braziel R, Rosenwald A, Lenz G, Wright G, Jaffe ES, Staudt L, Jares P, López-Guillermo A, Campo E.

Haematologica. 2011 Jul;96(7):996-1001. doi: 10.3324/haematol.2010.037408. Epub 2011 May 5.

31.

Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.

Gutiérrez-García G, Cardesa-Salzmann T, Climent F, González-Barca E, Mercadal S, Mate JL, Sancho JM, Arenillas L, Serrano S, Escoda L, Martínez S, Valera A, Martínez A, Jares P, Pinyol M, García-Herrera A, Martínez-Trillos A, Giné E, Villamor N, Campo E, Colomo L, López-Guillermo A; Grup per l'Estudi dels Limfomes de Catalunya I Balears (GELCAB).

Blood. 2011 May 5;117(18):4836-43. doi: 10.1182/blood-2010-12-322362. Epub 2011 Mar 25.

PMID:
21441466
32.

Initial features and outcome of cutaneous and non-cutaneous primary extranodal follicular lymphoma.

Fernández de Larrea C, Martínez-Pozo A, Mercadal S, García A, Gutierrez-García G, Valera A, Ghita G, Colomo L, Gainza E, Villamor N, Nomdedeu B, Estrach T, Montserrat E, Campo E, López-Guillermo A.

Br J Haematol. 2011 May;153(3):334-40. doi: 10.1111/j.1365-2141.2011.08596.x. Epub 2011 Mar 6.

PMID:
21375524
33.

FOXP1 molecular cytogenetics and protein expression analyses in primary cutaneous large B cell lymphoma, leg-type.

Espinet B, García-Herrera A, Gallardo F, Baró C, Salgado R, Servitje O, Estrach T, Colomo L, Romagosa V, Barranco C, Serrano S, Campo E, Pujol RM, Solé F.

Histol Histopathol. 2011 Feb;26(2):213-21. doi: 10.14670/HH-26.213.

34.

IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas.

Valera A, Balagué O, Colomo L, Martínez A, Delabie J, Taddesse-Heath L, Jaffe ES, Campo E.

Am J Surg Pathol. 2010 Nov;34(11):1686-94. doi: 10.1097/PAS.0b013e3181f3e29f.

35.

Endoscopic ultrasonography-guided brushing increases cellular diagnosis of pancreatic cysts: A prospective study.

Sendino O, Fernández-Esparrach G, Solé M, Colomo L, Pellisé M, Llach J, Navarro S, Bordas JM, Ginès A.

Dig Liver Dis. 2010 Dec;42(12):877-81. doi: 10.1016/j.dld.2010.07.009. Epub 2010 Sep 1.

PMID:
20810331
36.

Gall bladder and extrahepatic bile duct lymphomas: clinicopathological observations and biological implications.

Mani H, Climent F, Colomo L, Pittaluga S, Raffeld M, Jaffe ES.

Am J Surg Pathol. 2010 Sep;34(9):1277-86. doi: 10.1097/PAS.0b013e3181e9bb8b.

37.

Comparison of four prognostic scores in peripheral T-cell lymphoma.

Gutiérrez-García G, García-Herrera A, Cardesa T, Martínez A, Villamor N, Ghita G, Martínez-Trillos A, Colomo L, Setoain X, Rodríguez S, Giné E, Campo E, López-Guillermo A.

Ann Oncol. 2011 Feb;22(2):397-404. doi: 10.1093/annonc/mdq359. Epub 2010 Jul 14.

38.

Clinico-biological characterization and outcome of primary nodal and extranodal diffuse large B-cell lymphoma in the rituximab era.

Gutiérrez-García G, Colomo L, Villamor N, Arenillas L, Martínez A, Cardesa T, García-Herrera A, Setoain X, Rodríguez S, Ghita G, Abrisqueta P, Giné E, Bosch F, Campo E, Montserrat E, López-Guillermo A.

Leuk Lymphoma. 2010 Jul;51(7):1225-32. doi: 10.3109/10428194.2010.483301.

PMID:
20497002
39.

Endoscopic ultrasound-guided fine-needle aspiration and trucut biopsy in the diagnosis of gastric stromal tumors: a randomized crossover study.

Fernández-Esparrach G, Sendino O, Solé M, Pellisé M, Colomo L, Pardo A, Martínez-Pallí G, Argüello L, Bordas JM, Llach J, Ginès A.

Endoscopy. 2010 Apr;42(4):292-9. doi: 10.1055/s-0029-1244074. Epub 2010 Mar 30.

PMID:
20354939
40.

Endometrial stromal sarcoma. Is there a place for radiotherapy?

Valduvieco I, Rovirosa A, Colomo L, De San Juan A, Pahisa J, Biete A.

Clin Transl Oncol. 2010 Mar;12(3):226-30.

PMID:
20231128
41.

FOXP1 status in splenic marginal zone lymphoma: a fluorescence in situ hybridization and immunohistochemistry approach.

Baró C, Espinet B, Salido M, Colomo L, Luño E, Florensa L, Ferrer A, Salar A, Campo E, Serrano S, Solé F.

Histol Histopathol. 2009 Nov;24(11):1399-404. doi: 10.14670/HH-24.1399.

PMID:
19760589
42.

[A 45 year-old man suffering from toxic syndrome, anaemia and spleen enlargement].

Lluís Padierna M, Pagés M, Colomo L.

Med Clin (Barc). 2009 Nov 14;133(18):710-6. doi: 10.1016/j.medcli.2009.01.029. Epub 2009 Jun 4. Spanish. No abstract available.

PMID:
19500807
43.

Activation of the endoplasmic reticulum stress-associated transcription factor x box-binding protein-1 occurs in a subset of normal germinal-center B cells and in aggressive B-cell lymphomas with prognostic implications.

Balague O, Mozos A, Martinez D, Hernandez L, Colomo L, Mate JL, Teruya-Feldstein J, Lin O, Campo E, Lopez-Guillermo A, Martinez A.

Am J Pathol. 2009 Jun;174(6):2337-46. doi: 10.2353/ajpath.2009.080848. Epub 2009 Apr 23.

44.

High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma.

Carreras J, Lopez-Guillermo A, Roncador G, Villamor N, Colomo L, Martinez A, Hamoudi R, Howat WJ, Montserrat E, Campo E.

J Clin Oncol. 2009 Mar 20;27(9):1470-6. doi: 10.1200/JCO.2008.18.0513. Epub 2009 Feb 17.

PMID:
19224853
45.

Diagnosis of pleural malignant mesothelioma by EUS-guided FNA (with video).

Balderramo DC, Pellisé M, Colomo L, Sendino O, Fernández-Esparrach G, Ginès A.

Gastrointest Endosc. 2008 Dec;68(6):1191-2; dicussion 1192-3. doi: 10.1016/j.gie.2008.05.034. Epub 2008 Oct 25. No abstract available.

PMID:
18951127
46.

Increased serum tumor markers (CA125 and CA15.3) in primary plasma cell leukemia: a case report and review of the literature.

de Larrea CF, Cibeira MT, Vallansot R, Colomo L, Bladé J.

Clin Lymphoma Myeloma. 2008 Oct;8(5):312-4. doi: 10.3816/CLM.2008.n.045.

PMID:
18854288
47.

Primary cutaneous small/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome.

Garcia-Herrera A, Colomo L, Camós M, Carreras J, Balague O, Martinez A, Lopéz-Guillermo A, Estrach T, Campo E.

J Clin Oncol. 2008 Jul 10;26(20):3364-71. doi: 10.1200/JCO.2008.16.1307. Epub 2008 Jun 9.

PMID:
18541895
48.

Primary neuroendocrine small cell undifferentiated carcinoma of the parotid gland.

Jorcano S, Casado A, Berenguer J, Arenas M, Rovirosa A, Colomo L.

Clin Transl Oncol. 2008 May;10(5):303-6.

PMID:
18490250
49.

Diagnostic efficacy of bone scintigraphy, magnetic resonance imaging, and positron emission tomography in bone metastases of myxoid liposarcoma.

Conill C, Setoain X, Colomo L, Palacín A, Combalia-Aleu A, Pomés J, Marruecos J, Vargas M, Maurel J.

J Magn Reson Imaging. 2008 Mar;27(3):625-8. doi: 10.1002/jmri.21298.

PMID:
18307201
50.

Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma.

Mercadal S, Briones J, Xicoy B, Pedro C, Escoda L, Estany C, Camós M, Colomo L, Espinosa I, Martínez S, Ribera JM, Martino R, Gutiérrez-García G, Montserrat E, López-Guillermo A; Grup per l'Estudi dels Limfomes de Catalunya I Balears (GELCAB).

Ann Oncol. 2008 May;19(5):958-63. doi: 10.1093/annonc/mdn022. Epub 2008 Feb 25.

Supplemental Content

Loading ...
Support Center